首页> 外文期刊>The American surgeon. >Hepatocellular carcinoma arising within focal nodular hyperplasia.
【24h】

Hepatocellular carcinoma arising within focal nodular hyperplasia.

机译:局灶性结节性增生引起的肝细胞癌。

获取原文
获取原文并翻译 | 示例
       

摘要

To the Editor:There are extremely broad differential diagnoses for a patient presenting with a liver mass, which includes both benign and malignant lesions. Most liver lesions can be identified based on clinical scenario and radio-logic studies. However, they frequently pose a challenge for many clinicians. Benign liver tumors compose 3 to 5 per cent of all liver tumors with hemangioma (55-60%) and focal nodular hyperplasia (FNH) (21-27%) being most common. Adenomas comprise between 8 per cent and 19 per cent of benign liver tumors and are sometimes difficult to differentiate from other benign lesions and well-differentiated hepatocellular carcinoma (HCC) radiographically. Like FNH, adenomas typically display early contrast enhancement followed by rapid washout on both MRI and CT. FNH will demonstrate a characteristic "central scar" in two-thirds of lesions.
机译:致编辑:对于存在肝脏肿块(包括良性和恶性病变)的患者,存在极其广泛的鉴别诊断。可以根据临床情况和放射学研究确定大多数肝脏病变。但是,它们经常给许多临床医生带来挑战。良性肝肿瘤占所有肝肿瘤的3-5%,其中血管瘤(55-60%)和局灶性结节性增生(FNH)(21-27%)最为常见。腺瘤占良性肝肿瘤的8%至19%,有时难以通过影像学方法与其他良性病变和高分化肝细胞癌(HCC)区分开。像FNH一样,腺瘤通常显示出早期对比增强,然后在MRI和CT上快速冲洗。 FNH将在三分之二的病变中表现出特征性的“中央瘢痕”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号